首页> 美国卫生研究院文献>Rare Tumors >Neoadjuvant chemotherapy in the setting of locally advanced olfactory neuroblastoma with intracranial extension
【2h】

Neoadjuvant chemotherapy in the setting of locally advanced olfactory neuroblastoma with intracranial extension

机译:新辅助化疗在局部晚期嗅神经母细胞瘤伴颅内扩展的情况下

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Olfactory neuroblastoma (esthesioneuroblastoma) is a rare malignant tumor of neuroectodermal origin. With only about 1,000 cases reported, there are no clear guidelines regarding management of this disease. Intracranial extension and orbital involvement have been shown to be independent risk factors associated with poorer outcomes. We hereby report a case of a 46-year old male presented with an 8-month history of progressive nasal obstruction and intermittent right-sided epistaxis associated with anosmia and increased pressure sensation in and around the right eye. Further evaluation revealed a large enhancing heterogeneous cystic and solid mass in the right nasal cavity measuring 5.0×5.3×4.6 cm with extension superiorly into the anterior cranial fossa and frontal lobes, ethmoid and sphenoid sinuses. A biopsy of this mass confirmed high grade olfactory neuroblastoma. Because of the intra-cranial extension, a decision was made to start neoadjuvant chemotherapy with cisplatin and etoposide. The patient had very good response to this treatment on a repeat imaging study and went on to have resection of this mass. Post-operatively, he received radiation therapy to the tumor bed and 2 more cycles of chemotherapy. He has been followed now for more than 8 months with no evidence of disease recurrence.
机译:嗅觉神经母细胞瘤(esthesioneuroblastoma)是神经外胚层起源的一种罕见的恶性肿瘤。仅报告了约1,000例病例,尚无有关该疾病管理的明确指南。颅内扩张和眶受累已被证明是与不良预后相关的独立危险因素。我们在此报告一例46岁的男性,患者有8个月的进行性鼻塞和间歇性右侧鼻出血伴有嗅觉异常,右眼及其周围的压力感增加,有8个月的病史。进一步的评估显示,右鼻腔中有一个较大的增强型异质囊性和实性肿块,尺寸为5.0×5.3×4.6 cm,并延伸至颅前窝和额叶,筛窦和蝶窦。大量的活检证实为高度嗅觉神经母细胞瘤。由于颅内扩张,决定开始用顺铂和依托泊苷进行新辅助化疗。在重复的影像学研究中,患者对该治疗反应非常好,并继续切除了该肿物。术后,他接受了放射治疗,并接受了2个疗程的化疗。他已被追踪超过8个月,没有任何疾病复发的迹象。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号